Superworth

Oric Pharmaceuticals EPS ORIC

Diluted earnings per share by quarter and over the last twelve months, from 2019.

Last 12 months, to Jun 30, 2026
−$1.35
Latest quarter, Q2 FY26
−$0.38
Fiscal year 2025
−$1.52

Oric Pharmaceuticals' earnings per share was −$1.35 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.38.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.52n/a
FY2024−$1.82n/a
FY2023−$1.96n/a
FY2022−$2.25n/a
FY2021−$2.07n/a
FY2020−$6.65n/a
FY2019−$14.12n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.38n/a−$1.35
Q1 FY26−$0.34n/a−$1.44
Q4 FY25−$0.30n/a−$1.52
Q3 FY25−$0.33n/a−$1.73
Q2 FY25−$0.47n/a−$1.89
Q1 FY25−$0.42n/a−$1.87
Q4 FY24−$0.51n/a−$1.82
Q3 FY24−$0.49n/a−$1.80
Q2 FY24−$0.45n/a−$1.75
Q1 FY24−$0.37n/a−$1.80
Q4 FY23−$0.49n/a−$1.96
Q3 FY23−$0.44n/a−$1.99

Against its peers

Companies in Drug Manufacturers - General nearest Oric Pharmaceuticals' size, closest first, today.

CompanyEPS, 12 monthsGrowth
ORICOric Pharmaceuticals−$1.35
PCRXPacira BioSciences$0.35
ANABAnaptysbio$4.57
OMEROmeros$1.52
PAHCPhibro Animal Health$2.44+107% a year
ANIPANI Pharmaceuticals$4.70
AMPHAmphastar Pharmaceuticals$1.70−36% a year
HRMYHarmony Biosciences$3.09−0% a year
ABUSArbutus Biopharma$0.78
PBHPrestige Consumer Healthcare$3.57−16% a year
COLLCollegium Pharmaceutical$1.24+19% a year
Peer median$2.07

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Oric Pharmaceuticals

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.